Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Giacomo Miserocchi
Observed names:
G. Miserocchi,
MISEROCCHI, GIACOMO,
Miserocchi, G.,
Miserocchi, Giacomo
Institution:
Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori
Observed institutions:
Houston Methodist,
Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico,
Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori,
Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale",
Houston Methodist Research Institute
ORCID:
0000-0001-6618-1981
Observed ORCID:
0000-0001-6618-1981
OpenAlex ID:
A5074249448
Management and potentialities of primary cancer cultures in preclinical and translational studies
2017
·
Giacomo Miserocchi
, Laura Mercatali
, et al.
·
Journal of Translational Medicine
·
129
PDF
Development of a Patient-Derived Xenograft (PDX) of Breast Cancer Bone Metastasis in a Zebrafish Model
2016
·
Laura Mercatali
, Federico La Manna
, et al.
·
International Journal of Molecular Sciences
·
110
PDF
Current classification, treatment options, and new perspectives in the management of adipocytic sarcomas
2016
·
Alessandro De Vita
, Laura Mercatali
, et al.
·
OncoTargets and Therapy
·
106
Myxofibrosarcoma landscape: diagnostic pitfalls, clinical management and future perspectives
2022
·
Silvia Vanni
, Alessandro De Vita
, et al.
·
Therapeutic Advances in Medical Oncology
·
90
Lysyl oxidase engineered lipid nanovesicles for the treatment of triple negative breast cancer
2021
·
Alessandro De Vita
, Chiara Liverani
, et al.
·
Scientific Reports
·
82
PDF
Investigating the Mechanobiology of Cancer Cell–ECM Interaction Through Collagen-Based 3D Scaffolds
2017
·
Chiara Liverani
, Laura Mercatali
, et al.
·
Cellular and Molecular Bioengineering
·
73
The potential role of the extracellular matrix in the activity of trabectedin in UPS and L-sarcoma: evidences from a patient‐derived primary culture case series in tridimensional and zebrafish models
2021
·
Alessandro De Vita
, Federica Recine
, et al.
·
Journal of Experimental & Clinical Cancer Research
·
52
PDF
A Rationale for the Activity of Bone Target Therapy and Tyrosine Kinase Inhibitor Combination in Giant Cell Tumor of Bone and Desmoplastic Fibroma: Translational Evidences
2022
·
Alessandro De Vita
, Silvia Vanni
, et al.
·
Biomedicines
·
51
PDF
Three-dimensional collagen-based scaffold model to study the microenvironment and drug-resistance mechanisms of oropharyngeal squamous cell carcinomas
2021
·
Giacomo Miserocchi
, Claudia Cocchi
, et al.
·
Cancer Biology and Medicine
·
51
Diagnostic and Predictive Role of DLL3 Expression in Gastroenteropancreatic Neuroendocrine Neoplasms
2021
·
Chiara Liverani
, Alberto Bongiovanni
, et al.
·
Endocrine Pathology
·
49
Primary Culture of Undifferentiated Pleomorphic Sarcoma: Molecular Characterization and Response to Anticancer Agents
2017
·
Alessandro De Vita
, Federica Recine
, et al.
·
International Journal of Molecular Sciences
·
47
PDF
Myxofibrosarcoma primary cultures: molecular and pharmacological profile
2017
·
Alessandro De Vita
, Federica Recine
, et al.
·
Therapeutic Advances in Medical Oncology
·
41
PDF
Precision Medicine in Head and Neck Cancers: Genomic and Preclinical Approaches
2022
·
Giacomo Miserocchi
, Chiara Spadazzi
, et al.
·
Journal of Personalized Medicine
·
39
PDF
Unveiling the Genomic Basis of Chemosensitivity in Sarcomas of the Extremities: An Integrated Approach for an Unmet Clinical Need
2023
·
Silvia Vanni
, Valentina Fausti
, et al.
·
International Journal of Molecular Sciences
·
38
PDF
Combining preclinical tools and models to unravel tumor complexity: Jump into the next dimension
2023
·
Giacomo Miserocchi
, Martine Bocchini
, et al.
·
Frontiers in Immunology
·
37
PDF
Update on the role of trabectedin in the treatment of intractable soft tissue sarcomas
2017
·
Federica Recine
, Alberto Bongiovanni
, et al.
·
OncoTargets and Therapy
·
37
PDF
Clinical and translational implications of immunotherapy in sarcomas
2024
·
Federica Recine
, Silvia Vanni
, et al.
·
Frontiers in Immunology
·
36
Deciphering the Genomic Landscape and Pharmacological Profile of Uncommon Entities of Adult Rhabdomyosarcomas
2021
·
Alessandro De Vita
, Silvia Vanni
, et al.
·
International Journal of Molecular Sciences
·
36
PDF
The emerging role of cancer nanotechnology in the panorama of sarcoma
2022
·
Laura Mercatali
, Silvia Vanni
, et al.
·
Frontiers in Bioengineering and Biotechnology
·
35
PDF
Temozolomide Alone or Combined with Capecitabine for the Treatment of Metastatic Neuroendocrine Neoplasia: A “Real-World” Data Analysis
2020
·
Alberto Bongiovanni
, Chiara Liverani
, et al.
·
Neuroendocrinology
·
35
Case Report: Adult NTRK-Rearranged Spindle Cell Neoplasm: Early Tumor Shrinkage in a Case With Bone and Visceral Metastases Treated With Targeted Therapy
2022
·
Federica Recine
, Alessandro De Vita
, et al.
·
Frontiers in Oncology
·
33
PDF
Induction chemotherapy plus concomitant chemoradiotherapy in nasopharyngeal carcinoma: An updated network meta-analysis
2021
·
Alberto Bongiovanni
, Alessandro Vagheggini
, et al.
·
Critical Reviews in Oncology/Hematology
·
33
The Effect of Everolimus in an In Vitro Model of Triple Negative Breast Cancer and Osteoclasts
2016
·
Laura Mercatali
, Chiara Spadazzi
, et al.
·
International Journal of Molecular Sciences
·
33
PDF
Tumor-Stroma Crosstalk in Bone Tissue: The Osteoclastogenic Potential of a Breast Cancer Cell Line in a Co-Culture System and the Role of EGFR Inhibition
2017
·
Laura Mercatali
, Federico La Manna
, et al.
·
International Journal of Molecular Sciences
·
32
PDF
Novel S1R agonists counteracting NMDA excitotoxicity and oxidative stress: A step forward in the discovery of neuroprotective agents
2023
·
Pasquale Linciano
, Claudia Sorbi
, et al.
·
European Journal of Medicinal Chemistry
·
27
PDF
Show more works
View as search
Works count:
110
Citation count:
1,836
H-index:
27
I10-index:
47
Year
Topic
Type